KIRBY COX: Open Payments
NPI 1174168462 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,504 in 135 payments from 29 companies in 2025. Trend: 2023 $2,132 · 2024 $4,618 · 2025 $3,504
Food & beverage: $3,504
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $534 |
| ABBVIE INC. | 31 | $370 |
| Novartis Pharmaceuticals Corporation | 12 | $226 |
| EMD Serono, Inc. | 8 | $223 |
| Neurocrine BioSciences, Inc. | 10 | $221 |
| Biogen, Inc. | 7 | $161 |
| Abbott Laboratories | 1 | $139 |
| Genentech USA, Inc. | 7 | $138 |
| SK Life Science, Inc. | 5 | $128 |
| Insulet Corporation | 1 | $127 |
Products named: Briviact, KESIMPTA, Nayzilam, BOTOX, FREESTYLE LIBRE 3, Ocrevus Zunovo, OMNIPOD, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across LA — which companies pay providers there.
